Literature DB >> 22169865

Drug delivery: Relieving PEGylation.

Matthew C Parrott, Joseph M DeSimone.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22169865      PMCID： PMC4267756          DOI： 10.1038/nchem.1230

Source DB:  PubMed          Journal:  Nat Chem        ISSN： 1755-4330            Impact factor:   24.427


× No keyword cloud information.
  7 in total

1.  Poly(zwitterionic)protein conjugates offer increased stability without sacrificing binding affinity or bioactivity.

Authors:  Andrew J Keefe; Shaoyi Jiang
Journal:  Nat Chem       Date:  2011-12-11       Impact factor: 24.427

Review 2.  Protein therapeutics: a summary and pharmacological classification.

Authors:  Benjamin Leader; Quentin J Baca; David E Golan
Journal:  Nat Rev Drug Discov       Date:  2008-01       Impact factor: 84.694

3.  Rational design of a potent, long-lasting form of interferon: a 40 kDa branched polyethylene glycol-conjugated interferon alpha-2a for the treatment of hepatitis C.

Authors:  P Bailon; A Palleroni; C A Schaffer; C L Spence; W J Fung; J E Porter; G K Ehrlich; W Pan; Z X Xu; M W Modi; A Farid; W Berthold; M Graves
Journal:  Bioconjug Chem       Date:  2001 Mar-Apr       Impact factor: 4.774

Review 4.  PEGylation, successful approach to drug delivery.

Authors:  Francesco M Veronese; Gianfranco Pasut
Journal:  Drug Discov Today       Date:  2005-11-01       Impact factor: 7.851

5.  Functionalizable and ultra stable nanoparticles coated with zwitterionic poly(carboxybetaine) in undiluted blood serum.

Authors:  Wei Yang; Lei Zhang; Shanlin Wang; Andrew D White; Shaoyi Jiang
Journal:  Biomaterials       Date:  2009-10       Impact factor: 12.479

6.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.

Authors:  Sarah Wild; Gojka Roglic; Anders Green; Richard Sicree; Hilary King
Journal:  Diabetes Care       Date:  2004-05       Impact factor: 19.112

Review 7.  The impact of PEGylation on biological therapies.

Authors:  Francesco M Veronese; Anna Mero
Journal:  BioDrugs       Date:  2008       Impact factor: 5.807
  7 in total
  9 in total

1.  Simple Protein Modification Using Zwitterionic Polymer to Mitigate the Bioactivity Loss of Conjugated Insulin.

Authors:  Jinbing Xie; Yang Lu; Wei Wang; Hui Zhu; Zhigang Wang; Zhiqiang Cao
Journal:  Adv Healthc Mater       Date:  2017-03-24       Impact factor: 9.933

2.  Enhancing the anti-ovarian cancer activity of quercetin using a self-assembling micelle and thermosensitive hydrogel drug delivery system.

Authors:  Guangya Xu; Bin Li; Ting Wang; Jun Wan; Yan Zhang; Jingwei Huang; Yangmei Shen
Journal:  RSC Adv       Date:  2018-06-11       Impact factor: 4.036

3.  Efficacy and safety of scleral crosslinking using poly(ethylene glycol)ether tetrasuccinimidyl glutarate for form-deprivation myopia progression in rabbits.

Authors:  Yanbing Wang; Zhenquan Wu; Bingqian Liu; Jiang Lu; Silvia Tanumiharjo; Jianbing Huang; Xiujuan Zhao; Lin Lu
Journal:  RSC Adv       Date:  2021-09-27       Impact factor: 4.036

4.  Fabrication of genistein-loaded biodegradable TPGS-b-PCL nanoparticles for improved therapeutic effects in cervical cancer cells.

Authors:  Hongling Zhang; Gan Liu; Xiaowei Zeng; Yanping Wu; Chengming Yang; Lin Mei; Zhongyuan Wang; Laiqiang Huang
Journal:  Int J Nanomedicine       Date:  2015-03-27

5.  Enhancing the anti-colon cancer activity of quercetin by self-assembled micelles.

Authors:  Guangya Xu; Huashan Shi; Laibin Ren; Hongfeng Gou; Daoyin Gong; Xiang Gao; Ning Huang
Journal:  Int J Nanomedicine       Date:  2015-03-16

6.  Chitosan Nanolayered Cisplatin-Loaded Lipid Nanoparticles for Enhanced Anticancer Efficacy in Cervical Cancer.

Authors:  Jing-Yi Wang; Yu Wang; Xia Meng
Journal:  Nanoscale Res Lett       Date:  2016-11-25       Impact factor: 4.703

7.  Applying an innovative biodegradable self-assembly nanomicelles to deliver α-mangostin for improving anti-melanoma activity.

Authors:  Shuping Yang; Xiang Gao; Yihong He; Yuzhu Hu; Bocheng Xu; Zhiqiang Cheng; Mingli Xiang; Yongmei Xie
Journal:  Cell Death Dis       Date:  2019-02-15       Impact factor: 8.469

8.  Apelin-36-[L28A] and Apelin-36-[L28C(30kDa-PEG)] peptides that improve diet induced obesity are G protein biased ligands at the apelin receptor.

Authors:  Duuamene Nyimanu; Rhoda E Kuc; Thomas L Williams; Maria Bednarek; Philip Ambery; Lutz Jermutus; Janet J Maguire; Anthony P Davenport
Journal:  Peptides       Date:  2019-08-28       Impact factor: 3.750

9.  Priming the body to receive the therapeutic agent to redefine treatment benefit/risk profile.

Authors:  Matthieu Germain; Marie-Edith Meyre; Laurence Poul; Marion Paolini; Céline Berjaud; Francis Mpambani; Maxime Bergere; Laurent Levy; Agnès Pottier
Journal:  Sci Rep       Date:  2018-03-19       Impact factor: 4.379
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.